Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283361 · ClinicalTrials.gov registry record · Phase 2
ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure
A Phase 2 study, sponsored by Zealand Pharma.
- Terminated
- Registry status
- Phase 2
- Development phase
- 130
- Enrollment target
NCT00283361: Clinical Trial Phase 2 study, sponsored by Zealand Pharma.
NCT00283361 is a Phase 2 study that was terminated before completion, run by Zealand Pharma. The registered enrollment target is 130 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00283361, a Phase 2 study, was terminated before completion, sponsored by Zealand Pharma.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 130 participants
- Enrollment target
Study Summary
The main purpose of this study is to see if the experimental drug ZP120, when given with the approved drug furosemide to patients with acute or sub-acute heart failure, can reduce the amount of fluid in the patients' lungs and make breathing easier.
Interventions
- DRUG ZP120
- PROCEDURE I.v. catherization
- PROCEDURE 6-minutes walk performance
- BEHAVIORAL Dyspnea severity assessment
- PROCEDURE Blood sampling for laboratory tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
Why NCT00283361 stopped before completion
NCT00283361 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 5 interventions - of which ZP120 is the first listed.
NCT00283361 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00283361 about?
NCT00283361 is a clinical study titled "ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure". The main purpose of this study is to see if the experimental drug ZP120, when given with the approved drug furosemide to patients with acute or sub-acute heart failure, can reduce the amount of fluid in the patients' lungs and make breathing easier.
What is the current status of trial NCT00283361?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 130 participants. The study started on 2006-01. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00283361?
The interventions under investigation include: ZP120 (DRUG), I.v. catherization (PROCEDURE), 6-minutes walk performance (PROCEDURE), Dyspnea severity assessment (BEHAVIORAL), Blood sampling for laboratory tests (PROCEDURE).
Who is sponsoring clinical trial NCT00283361?
This trial is sponsored by Zealand Pharma, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00283361's enrollment target sits among peer trials
130 543rd of 2000 higher than 1,448 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia